Richard Furie, MD

Richard Furie, MD, is Chief of the Division of Rheumatology at Northwell Health.

Articles by Richard Furie, MD

Insights: Obinutuzumab Faces Integration Challenges, Long-Term Potential in Lupus Nephritis

ByLuke Halpern, Associate Editor,Richard Furie, MD

March 11th 2025

Expert: Obinutuzumab Shows Promise in Lupus Nephritis, Reinforcing Role in High-Disease Patients

ByLuke Halpern, Associate Editor,Richard Furie, MD

March 4th 2025

Obinutuzumab is effective in reducing proteinuria and preserving kidney function in lupus nephritis, with consistent benefits across high-disease activity subgroups.

Richard Furie, MD

Articles by Richard Furie, MD

Insights: Obinutuzumab Faces Integration Challenges, Long-Term Potential in Lupus Nephritis

Expert: Obinutuzumab Shows Promise in Lupus Nephritis, Reinforcing Role in High-Disease Patients

Latest Updated Articles

Trending on Pharmacy Times

Diabetes Awareness Month Opens Amid New T1D, T2D Approvals

FDA Grants Accelerated Approval to First Plasmid DNA-Based Immunotherapy for Recurrent Respiratory Papillomatosis

Very Low Protein Intake Tied to Higher Kidney Failure Risk in CKD

Community Pharmacists Guide Patients New to Glucose Monitoring

C difficile Survivor and PLF Board Member Describes the Counseling Gap Pharmacists Can Close